[Lung Adenocarcinoma with EGFR Exon 20 H773_V774delinsLM Mutation Sensitive to Furmonertinib: A Case Report] [0.03%]
一例奥美替尼敏感的EGFR exon20插入突变（H773_V774delinsLM）肺腺癌患者报告
Rongzhen Li,Yan Xu,Xiaoxing Gao et al.
Rongzhen Li et al.
Epidermal growth factor receptor (EGFR) exon 20 mutations represent a rare subset of genetic alterations in non-small cell lung cancer (NSCLC). Among them, the complex mutation H773_V774delinsLM is exceedingly uncommon, accounting for only ...
[Case Report and Literature Review of Severe Anemia Secondary to Chemotherapy Combined with PD-1 Monoclonal Antibody Immunotherapy for Lung Adenocarcinoma] [0.03%]
重症化疗联合PD-1单克隆抗体免疫治疗所致贫血的病例报告和文献复习
Yaowen Hu,Jing Zhao,Xiaoxing Gao et al.
Yaowen Hu et al.
Programmed cell death 1 (PD-1) inhibitor therapy for lung adenocarcinoma may induce rare but severe hematologic adverse events, including severe anemia. Although glucocorticoids are recommended for managing immune-related adverse events, th...
[Research Progress and Challenges of Oligometastasis in Non-small Cell Lung Cancer] [0.03%]
【非小细胞肺癌寡转移的研究进展和挑战】
Songzhen Li,Tianhang Shao,Shuyang Yao
Songzhen Li
Oligometastasis represents a transitional state between early localized disease and widespread metastasis, characterized by limited tumor burden and distinct tumor biological behavior. Due to the relatively restricted number of metastatic l...
Ying Xiao,Xiaobo Chen,Xinghe Tong et al.
Ying Xiao et al.
In recent years, the incidence of multiple primary lung cancer (MPLC) has been increasing, and it cannot be ignored in clinical practice. The treatment of MPLC is still controversial, but surgical treatment is recognized as the most importa...
[Recent Advances in the Treatment of Non-small Cell Lung Cancer with Brigatinib] [0.03%]
brigatinib治疗非小细胞肺癌的新进展
Jia Yu,Shengxiang Ren
Jia Yu
The discovery of anaplastic lymphoma kinase (ALK) tyrosine kinase gene rearrangement mutations in non-small cell lung cancer (NSCLC) has driven continuous advancements in ALK-targeted therapies. The next generation of ALK tyrosine kinase in...
[Clinical Characteristics, MAML2 Gene Rearrangement and Prognosis of Pulmonary Mucoepidermoid Carcinoma] [0.03%]
肺黏液表皮样癌的临床特点、MAML2基因易位及预后分析
Jianrong Bai,Meng Yan,Lingchuan Guo et al.
Jianrong Bai et al.
Background: Primary pulmonary mucoepidermoid carcinoma (PMEC) is an exceedingly rare malignancy originating from bronchial submucosal glands, accounting for
[Effect of Lymph Node Clearance Modalities on Chronic Cough after Surgery in Non-small Cell Lung Cancer] [0.03%]
不同淋巴结清扫方式对非小细胞肺癌患者术后慢性咳嗽的影响
Zekai Zhang,Gaoxiang Wang,Zhengwei Chen et al.
Zekai Zhang et al.
Background: Lung cancer has the highest mortality rate among all malignant tumors, and non-small cell lung cancer (NSCLC) accounts for about 80%-85% of all lung cancers. Lobectomy and lymph node dissection are one of the ...
[Trend of Death and Years of Life Lost Caused by Lung Cancer in Handan, 2017-2023] [0.03%]
[2017-2023年河北省邯郸市肺癌死亡及生命损失年的趋势分析]
Nianzhen Fang,Yang Zhao,Yang Yang
Nianzhen Fang
Background: Lung cancer ranks as the foremost cause of cancer-related deaths in China, significantly undermining population health and longevity. By analyzing the trends of death and years of life lost caused by lung canc...
[Analysis of Efficacy and Safety of Neoadjuvant Immunochemotherapy in Patients with Stage IB-IIIB Non-small Cell Lung Cancer] [0.03%]
ⅠB～ⅢB期非小细胞肺癌新辅助免疫化疗疗效及安全性分析
Zihao Li,Xin Wang,Yulong Wang et al.
Zihao Li et al.
Background: Neoadjuvant immunochemotherapy has emerged as an indispensable therapeutic modality for non-small cell lung cancer (NSCLC). However, its clinical application experience remains limited, and the associations be...
[Phrenic Nerve Cryotherapy for Preventing Prolonged Air Leak During VATS Lobectomy] [0.03%]
低温等离子消融在治疗难治性心房颤动中的作用：前瞻性随机对照试验
Qingyu Meng,Yongkun Wu,Yufei Wang et al.
Qingyu Meng et al.
Background: Video-assisted thoracoscopic surgery (VATS) lobectomy is the primary surgical treatment for lung cancer. A significant factor affecting postoperative recovery is prolonged air leak (PAL). Despite numerous clin...
Randomized Controlled Trial
Zhongguo fei ai za zhi = Chinese journal of lung cancer. 2025 Jun 20;28(6):405-414. DOI:10.3779/j.issn.1009-3419.2025.102.23 2025